MyAverix Finance
F · Healthcare
Sutro Biopharma Inc. (S090)
Biotechnology
Sutro Biopharma Inc. (S090) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $341.29M, P/E ratio is 18.00, net margin is -186.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for S090
Sutro Biopharma Inc. (S090) — FAQ
What is Sutro Biopharma Inc.'s market cap?
Sutro Biopharma Inc. (S090) has a reported market cap of $341.29M (data as of 2026-03-30).
What is S090's P/E ratio?
The price-to-earnings (P/E) ratio for Sutro Biopharma Inc. (S090) is 18.00 (data as of 2026-03-30).
Does Sutro Biopharma Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Sutro Biopharma Inc. (S090). Check the MyAverix Finance app for the latest dividend data.
What sector is Sutro Biopharma Inc. in?
Sutro Biopharma Inc. (S090) is classified in the Healthcare sector (Biotechnology industry).
What exchange is S090 listed on?
S090 is listed on F.
What is Sutro Biopharma Inc.'s net margin?
Sutro Biopharma Inc. (S090) reports a net margin of -186.5% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.